Zobrazeno 1 - 10
of 40
pro vyhledávání: '"L. Hammershaimb"'
Autor:
J. Shultz, Nancy E. Kemeny, R. Isaacs, Charles D. Blanke, Malcolm J. Moore, John Cox, Daniel G. Haller, B. Kasimis, M. Modiano, Richard L. Schilsky, D. Carlin, J. Fleagle, L. Hammershaimb
Publikováno v:
Annals of Oncology. 13:87-91
Background Trimetrexate (TMTX) biochemically modulates 5-fluorouracil (5-FU) and leucovorin (LCV). Two phase II trials demonstrated promising activity for TMTX/5-FU/LCV in patients with untreated advanced colorectal cancer (ACC). This trial was desig
Autor:
N. J. Petrelli, Y. Z. Patt, L Hammershaimb, Frederick L. Moffat, F. S. Whaley, C. M. Pinsky, David M. Goldenberg
Publikováno v:
Journal of Clinical Oncology. 14:2295-2305
PURPOSE To assess the performance and the potential clinical impact of a new antibody imaging agent, CEA-Scan (Immunomedics Inc, Morris Plains, NJ), in 210 presurgical patients with advanced recurrent or metastatic colorectal carcinomas. METHODS CEA-
Publikováno v:
Annals of oncology, 13(1), 92-94. Oxford University Press
Annals of Oncology, 13, 92-4
Annals of Oncology, 13, 1, pp. 92-4
Annals of Oncology, 13, 92-4
Annals of Oncology, 13, 1, pp. 92-4
Item does not contain fulltext BACKGROUND: Two randomised studies were performed with trimetrexate (TMTX) as a biochemical modulator of 5-fluorouracil (5-FU)/leucovorin (LV) in advanced colorectal cancer (ACC), one in Europe and one in the United Sta
Autor:
S. Saletan, P. Alaerts, A. Carver, A Forrest, Nadine Crespeigne, Martine Piccart, Nicholas N.R. Bachur, Dominique de Valeriola, Pierre Dodion, J. D. Kantrowitz, F. Wery, L. Hammershaimb, Joseph Kerger, R. Rastogi, Merrill J. Egorin
Publikováno v:
Annals of Oncology. 2:589-596
Forty-six patients with refractory solid malignancies received the new platinum complex [2,2-bis(aminomethyl)-1,3-propanediol-N-N'] [1,1-cyclobutanedicarboxylato] [(2-)0,0')] platinum (zeniplatin). Zeniplatin was given, without hydration or mannitol,
Autor:
T. Skovsgaard, C.J.A. Punt, L. Hammershaimb, J. Douma, J. Schüller, J. J. Croles, J. Zhang, E. W. Muller, H. Lochs, H.J. Keizer, C. H. H. Ten Napel
Publikováno v:
Annals of Oncology, 13, 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Item does not contain fulltext BACKGROUND: Trimetrexate (TMTX) is a biochemical modulator of 5-fluorouracil (5-FU) and leucovorin (LV). Phase II trials have shown promising activity of 5-FU/LV/TMTX in patients with advanced colorectal cancer (ACC). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4827ac55aa0af8f3033d5953c11d28c7
http://hdl.handle.net/2066/185518
http://hdl.handle.net/2066/185518
Autor:
D. Niu, N. Willich, G. Albert, J. Ammon, J. Zhang, A. Monnier, G. Schmitt, L. Hammershaimb, Jens Buentzel
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 51:85
Autor:
L Hammershaimb, J Berille, J.-L Schmidt, S Coughlin, F Gamza, Y Kim, E Lebras, J.-P Bizzari, Robert Olivares, L Lelann, N Pham Tran
Publikováno v:
Lung Cancer. 29:30
Autor:
J. von Pawel, Anna Pluzanska, J Rodriguez, J Berille, Michael Millward, Y Kim, L Hammershaimb, Chandra P. Belani, Lionel Bosquée, Vera Gorbounova, Frank V. Fossella, F Gamza
Publikováno v:
Lung Cancer. 29:60
Publikováno v:
Lung Cancer. 29:22
Autor:
Frances A. Shepherd, G Koch, L Hammershaimb, A Rodgers, F Gamza, Y.P Kim, S Durrleman, J Berille, Frank V. Fossella, J.-P Bizzari
Publikováno v:
Lung Cancer. 29:59